RxDoctor Payments Data

Daniel Bach, MD

Dermatology · Beverly Hills, CANPI 1528407780

Payments from drug & device makers

$10,300in general payments, 2019–2025

Across 385 payments — averaging $26.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$1K
  • Sanofi$1K
  • Novartis$703
  • Regeneron Healthcare Solutions, Inc.$691
  • UCB, Inc.$662
  • plus $4K from 21 others
$7,440in research payments, 2019–2025

Across 3 payments — averaging $2480.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$7K

What the payments were for

  • Travel & lodging$100%
  • Food & beverage$9,91596%
  • Education$3754%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,300 in reported general payments places this provider in the 75th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California

Medicare billing

Part B allowed, 2024
$137,668
Medicare patients
371
Services billed
1,900

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab45$170,563
Tacrolimus63$7,911
Clobetasol Propionate105$7,025
Azelaic Acid32$3,790
Fluocinonide89$3,764
Clindamycin Phosphate45$3,496
Ketoconazole247$3,086
Triamcinolone Acetonide216$2,713
CiclopiroxCiclopirox Olamine150$2,698
Fluorouracil35$2,670
Tretinoin32$2,094
Metronidazole25$2,010
Desonide18$1,319
Doxycycline Monohydrate21$812
ValacyclovirValacyclovir Hcl14$631

Paid to pharmacies, not to this prescriber.

Other dermatology in Beverly Hills

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →